Selenium May Be Effective Against Breast Cancer
November 10, 2014
U.S. Pharmacist- Research conducted at Texas Tech University (TTU) shows that selenium, when attached to the leading clinical chemotherapeutic monoclonal antibody (Mab) for a type of breast cancer, can more effectively kill the cancer cells. About 20% of cells have overexpressed growth receptors (HER2+ receptors) on the cancer cells, which cause uncontrolled cancer
Research conducted at Texas Tech University (TTU) shows that selenium, when attached to the leading clinical chemotherapeutic monoclonal antibody (Mab) for a type of breast cancer, can more effectively kill the cancer cells.